The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Apexxnar



Pfizer Europe MA EEIGEU/1/21/1612/001-006

Main Information

Trade NameApexxnar
Active SubstancesPneumococcal polysaccharide serotype 1
Pneumococcal Polysaccharide Serotype 3
Pneumococcal polysaccharide serotype 4
Pneumococcal polysaccharide serotype 5
Pneumococcal Polysaccharide Serotype 6A
Pneumococcal polysaccharide serotype 7f
Pneumococcal Polysaccharide Serotype 8
Pneumococcal polysaccharide serotype 9v
Pneumococcal Polysaccharide Serotype 10A
Pneumococcal Polysaccharide Serotype 11A
Pneumococcal Polysaccharide Serotype 12F
Pneumococcal polysaccharide serotype 14
Pneumococcal Polysaccharide Serotype 15B
Pneumococcal polysaccharide serotype 18c
Pneumococcal Polysaccharide Serotype 19A
Pneumococcal polysaccharide serotype 19f
Pneumococcal Polysaccharide Serotype 22F
Pneumococcal polysaccharide serotype 23f
Pneumococcal Polysaccharide Serotype 33F
Dosage FormSuspension for injection
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/21/1612/001-006

Group Information

ATC CodeJ07AL02 pneumococcus, purified polysaccharides antigen conjugated

Status

License statusAuthorised
Licence Issued14/02/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back